methylprednisolone has been researched along with dimethyl fumarate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fox, RJ; Giovannoni, G; Gold, R; Havrdova, E; Kappos, L; Kita, M; Sarda, SP; Viglietta, V; Yang, M; Zhang, R | 1 |
1 review(s) available for methylprednisolone and dimethyl fumarate
Article | Year |
---|---|
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-related Hospitalizations: Integrated Analysis of the Delayed-release Dimethyl Fumarate Phase III Studies.
Topics: Adult; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dimethyl Fumarate; Female; Glatiramer Acetate; Hospitalization; Humans; Immunosuppressive Agents; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Randomized Controlled Trials as Topic | 2015 |